Great Portland Estates PLC
16 January 2003
Great Portland Estates P.L.C. announces £74.6m of property disposals
Great Portland Estates P.L.C. ('GPE') announces it has exchanged contracts to
sell three properties in three separate transactions for an aggregate cash
consideration of £74.6 million. These disposals are in line with the company's
stated strategy of selling mature or ex-growth assets and bring total sales
since March 2002 to £198.4 million against a March 2002 valuation of £197.6
million. The properties sold are as follows:
350/354 Oxford Street, London, W1 - a rack rented property comprising a retail
unit of 14,000 sq. ft. at basement, ground and mezzanine level let to Clinton
Cards on a lease until June 2013 at a rent of £1.57 million per annum,
equivalent to £450 per sq. ft. Zone A. The upper floors of the building are let
on a 110 year lease at a fixed peppercorn rent to a hotel operator. The property
was sold to an Irish private investor for £25.4 million, which shows a net
initial yield to the purchaser of 5.8%.
King's Walk Shopping Mall, King's Road, London, SW3 - a combination of 120
King's Road, the King's Walk Shopping Mall and Ranelagh House, a residential
block at the rear of the property. In total, it comprises 47,300 sq. ft. of
commercial space, 50 flats all sold off on long leases and 69 underground car
parking spaces, producing an aggregate gross rental income of £1.6 million per
annum. Principal tenants include Gap, Virgin and Easyinternet Cafe. O&H
Properties paid cash consideration of £25.8 million representing a net initial
yield of 6%.
Knollys House & Stephenson House, Cherry Orchard Road, Croydon - Triton Property
Fund, managed by UBS Global Asset Management, has paid £23.4 million for the
freehold interest in this 1960's office building. The property, which is
adjacent to the East Croydon railway station, is largely unrefurbished and
comprises 180,000 sq. ft.. The building produces a gross income of £2.77
million per annum (a net initial yield to the purchaser of 11.25%) but requires
large scale refurbishment. Half of the income is overrented and well secured for
a further 51/2 years, with the remaining income short term. Principal tenants
include The Secretary of State for Health, BRB (Residuary) and Jacobs
Engineering.
Toby Courtauld, Chief Executive said, 'The sale of these properties was planned
as part of a review of our assets last summer. We have taken advantage of
hardening retail yields to sell our Oxford Street and King's Road holdings in to
the strong demand from private investors. These assets are mature and we see
prime unit retail rents levelling off. The sale of Croydon is part of the
orderly rationalisation of assets outside central London and follows the recent
sale of Weybridge Business Park in the Thames Valley, bringing the proportion of
our portfolio in Central London up to 94%.'
Contact: Great Portland Estates P.L.C. 020 7580 3040
Toby Courtauld, Chief Executive
Robert Noel, Property Director
Finsbury Group 020 7251 3801
Edward Orlebar
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.